Cocrystal is a clinical stage biotechnology company which develops novel medicines for use in the treatment of human viral diseases. Cocrystal has developed proprietary structure based drug design technology and antiviral nucleoside chemistry to create first in class and best in class antiviral drug candidates. Our focus is to pursue the development and commercialization of broad spectrum antiviral drug candidates that will transform the treatment and prophylaxis of hepatitis C, Influenza, and Norovirus. By concentrating our research and development efforts on viral replication inhibitors, we plan to leverage our infrastructure and expertise in these areas.
Quote | Cocrystal Pharma Inc. (NASDAQ:COCP)
Last: | $2.38 |
---|---|
Change Percent: | 0.43% |
Open: | $2.29 |
Close: | $2.38 |
High: | $2.4952 |
Low: | $2.29 |
Volume: | 62,705 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Cocrystal Pharma Inc. (NASDAQ:COCP)
BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in the highly pathogenic avian influenza A (H5N1) PB2 protein recently identified in infected dairy cattle, according to recently ...
2024-05-13 08:56:43 ET More on Cocrystal Pharma Seeking Alpha’s Quant Rating on Cocrystal Pharma Historical earnings data for Cocrystal Pharma Financial information for Cocrystal Pharma Read the full article on Seeking Alpha For further details...
Message Board Posts | Cocrystal Pharma Inc. (NASDAQ:COCP)
Subject | By | Source | When |
---|---|---|---|
$COCP Cocrystal Pharma Inc | mick | investorshub | 04/30/2023 11:27:55 PM |
This is a great time to add a | tredenwater2 | investorshub | 04/28/2023 10:04:06 PM |
https://en.wikipedia.org/wiki/Fred_Hassan | joe_techi | investorshub | 04/27/2023 8:19:18 PM |
$COCP Cocrystal Pharma Inc | mick | investorshub | 04/25/2023 5:31:18 PM |
hi dare friend , the scoop school still | mick | investorshub | 04/25/2023 5:30:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in the highly pathogenic avian influenza A (H5N1) PB2 protein recently identified in infected dairy cattle, according to recently ...
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human...